COVID-19 convalescent plasma as long-term therapy in immunodeficient patients? - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33901641/
1 Special Hospital for Pulmonary Diseases, Rockefellerova 3, 10000 Zagreb, Croatia. Electronic address: [email protected]. 2 University of Zagreb, Centre for Research and Knowledge Transfer in Biotechnology, Rockefellerova 10, 10000 Zagreb,...
-
Mark Fesler4yrGiven the low seroconversion rates in preliminary reports of covid vaccination in blood cancer patients, this approach makes sense and may be feasible as supply can be enhanced by cryopreservation
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33909455/
1 Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA. 2 Department of Hematology, University Hospital of Essen, Essen, Germany. 3 Department of Radiation Oncology, Stanford University...
-
Mark Fesler4yrThis report makes clinical sense in that more clinically urgent cases, which often have aggressive features such as high disease bulk and advanced stage, would be associated with more circulating Show More
A Case Report of a Primary Conjunctival Diffuse Large B-Cell Lymphoma: Keeping an Eye out Following a Nasopharyngeal Carcinoma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33880260/
Primary diffuse large B cell lymphoma of the conjunctiva is a rare disease. In this article, we report the case of a 40-year-old man who had previously been treated with...
-
Mark Fesler4yrMany tests were performed to stage this patient other than a pet/ct, which is considered the standard of care for staging dlbcl
Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33889489/
Chimeric antigen receptor T-cell (CAR-T) therapy is a novel treatment for various types of hematologic malignancy. We presented a case of refractory diffuse large B cell lymphoma patient who developed...
-
Mark Fesler4yrThis report would benefit from a more detailed description of anc depression depth and duration as well as steroid dose/duration and prophylaxis of IFI
-
Naveed Saleh, MD, MS – Skipta Team4yrPlease feel free to share your thoughts on this study.
Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33881464/
Despite central nervous system (CNS) relapse occurring in >10% of high-risk diffuse large B-cell lymphoma (DLBCL) patients, the role of CNS-directed prophylaxis is controversial in the absence of randomized controlled Show More
Key Points
• In the current retrospective study, researchers assessed the safety and efficacy of prophylactic high-dose methotrexate (HD-MTX) with regard to CNS relapse in 258 recently diagnosed high-risk DLBCL patients receiving R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). This analysis was based on the...
Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33881464/
Despite central nervous system (CNS) relapse occurring in >10% of high-risk diffuse large B-cell lymphoma (DLBCL) patients, the role of CNS-directed prophylaxis is controversial in the absence of randomized controlled...
-
Mark Fesler4yrThis is consistent with other recent studies presented at ash 2020 of the lack of benefit at reducing secondary cns lymphoma with hdmtx prophylaxis. In spite of this, my Show More